Literature DB >> 19397582

Improved logrank-type tests for survival data using adaptive weights.

Song Yang1, Ross Prentice.   

Abstract

For testing for treatment effects with time-to-event data, the logrank test is the most popular choice and has some optimality properties under proportional hazards alternatives. It may also be combined with other tests when a range of nonproportional alternatives are entertained. We introduce some versatile tests that use adaptively weighted logrank statistics. The adaptive weights utilize the hazard ratio obtained by fitting the model of Yang and Prentice (2005, Biometrika 92, 1-17). Extensive numerical studies have been performed under proportional and nonproportional alternatives, with a wide range of hazard ratios patterns. These studies show that these new tests typically improve the tests they are designed to modify. In particular, the adaptively weighted logrank test maintains optimality at the proportional alternatives, while improving the power over a wide range of nonproportional alternatives. The new tests are illustrated in several real data examples.

Entities:  

Mesh:

Year:  2009        PMID: 19397582      PMCID: PMC2998240          DOI: 10.1111/j.1541-0420.2009.01243.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  Adaptive test for testing the difference in survival distributions.

Authors:  Monika Pecková; Thomas R Fleming
Journal:  Lifetime Data Anal       Date:  2003-09       Impact factor: 1.588

2.  The efficiency of a weighed log-rank test under a percent error misspecification model for the log hazard ratio.

Authors:  D M Zucker
Journal:  Biometrics       Date:  1992-09       Impact factor: 2.571

Review 3.  Statistical issues arising in the Women's Health Initiative.

Authors:  Ross L Prentice; Mary Pettinger; Garnet L Anderson
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

4.  An adaptive weighted log-rank test with application to cancer prevention and screening trials.

Authors:  S G Self
Journal:  Biometrics       Date:  1991-09       Impact factor: 2.571

5.  Adjusting for early treatment termination in comparative clinical trials.

Authors:  S W Lagakos; L L Lim; J M Robins
Journal:  Stat Med       Date:  1990-12       Impact factor: 2.373

6.  Analysis of survival data by the proportional odds model.

Authors:  S Bennett
Journal:  Stat Med       Date:  1983 Apr-Jun       Impact factor: 2.373

7.  A two-sample censored-data rank test for acceleration.

Authors:  N E Breslow; L Edler; J Berger
Journal:  Biometrics       Date:  1984-12       Impact factor: 2.571

8.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

9.  Modification of the percutaneous approach to peritoneal dialysis catheter placement under peritoneoscopic visualization: clinical results in 78 patients.

Authors:  N S Nahman; D F Middendorf; W H Bay; R McElligott; S Powell; J Anderson
Journal:  J Am Soc Nephrol       Date:  1992-07       Impact factor: 10.121

10.  A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer       Date:  1982-05-01       Impact factor: 6.860

  10 in total
  13 in total

1.  Partitioned log-rank tests for the overall homogeneity of hazard rate functions.

Authors:  Yukun Liu; Guosheng Yin
Journal:  Lifetime Data Anal       Date:  2016-03-19       Impact factor: 1.588

2.  Comparison of multiple hazard rate functions.

Authors:  Zhongxue Chen; Hanwen Huang; Peihua Qiu
Journal:  Biometrics       Date:  2015-09-22       Impact factor: 2.571

3.  A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.

Authors:  Song Yang; Walter T Ambrosius; Lawrence J Fine; Adam P Bress; William C Cushman; Dominic S Raj; Shakaib Rehman; Leonardo Tamariz
Journal:  Clin Trials       Date:  2018-04-19       Impact factor: 2.486

4.  A versatile test for equality of two survival functions based on weighted differences of Kaplan-Meier curves.

Authors:  Hajime Uno; Lu Tian; Brian Claggett; L J Wei
Journal:  Stat Med       Date:  2015-07-20       Impact factor: 2.373

5.  Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations.

Authors:  Lu Tian; Haoda Fu; Stephen J Ruberg; Hajime Uno; Lee-Jen Wei
Journal:  Biometrics       Date:  2017-09-12       Impact factor: 2.571

6.  RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas.

Authors:  Andrew E Blum; Srividya Venkitachalam; Yan Guo; Ann Marie Kieber-Emmons; Lakshmeswari Ravi; Apoorva K Chandar; Prasad G Iyer; Marcia I Canto; Jean S Wang; Nicholas J Shaheen; Jill S Barnholtz-Sloan; Sanford D Markowitz; Joseph E Willis; Yu Shyr; Amitabh Chak; Vinay Varadan; Kishore Guda
Journal:  Cancer Res       Date:  2016-08-08       Impact factor: 12.701

7.  Is it time for the weighted log-rank test to play a more important role in confirmatory trials?

Authors:  Zheng Su; Ming Zhu
Journal:  Contemp Clin Trials Commun       Date:  2017-09-18

8.  A systematic review of the quality of conduct and reporting of survival analyses of tuberculosis outcomes in Africa.

Authors:  Moses M Ngari; Susanne Schmitz; Christopher Maronga; Lazarus K Mramba; Michel Vaillant
Journal:  BMC Med Res Methodol       Date:  2021-04-27       Impact factor: 4.615

9.  Estimation of treatment effects in weighted log-rank tests.

Authors:  Ray S Lin; Larry F León
Journal:  Contemp Clin Trials Commun       Date:  2017-09-19

10.  Clinical risk prediction with random forests for survival, longitudinal, and multivariate (RF-SLAM) data analysis.

Authors:  Shannon Wongvibulsin; Katherine C Wu; Scott L Zeger
Journal:  BMC Med Res Methodol       Date:  2019-12-31       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.